Search All News
The third authorized vaccine provides protection, particularly against severe illness and death, with just one shot, says Columbia's Jason Zucker, MD.
Jessica Justman, MD, an infectious disease specialist and epidemiologist at Columbia, says vaccinated people still need to take some precautions for now.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.
- December 21, 2020
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
- November 30, 2020
Columbia’s Evelyn Berger-Jenkins, MD, has co-authored new recommendations to help pediatricians address emotional and behavioral health issues in children during the COVID-19 pandemic.
- November 30, 2020
On World AIDS Day, David Ho, MD, received the National Leadership Recognition Award from the National AIDS Memorial and spoke at a virtual event about the impacts of HIV/AIDS and COVID-19.
- November 19, 2020
Columbia University COVID researchers are working to improve coronavirus testing, find new antivirals, and develop new ways to prevent transmission.
- November 16, 2020
A new nationwide study of more than 50,000 individuals—coordinated by Columbia researchers—is now underway to determine factors that predict disease severity and long-term health impacts of COVID-19.
- November 5, 2020
Compared with adults, children produce a very different antibody response after infection with the new coronavirus, SARS-CoV-2, suggesting they clear the virus easily.